FDA Drug recall D-0785-2021
Lidocaine Ointment USP, 5% Rx Only, Net Wt 35.44 g(1 1/4 oz)packaged in a laminat tube, Teligent Pharma, Inc
- FDA Drug
- Class III
- terminated
- Published 2021-09-08
On 2021-09-08 the FDA classified a Class III recall of Lidocaine Ointment USP, 5% Rx Only, Net Wt 35.44 g(1 1/4 oz)packaged in a laminat tube, Teligent Pharma, Inc by Teligent Pharma, citing failed Viscosity Specifications: lot does not meet specification for Viscosity, which was determined through routine testing.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0785-2021 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2021-07-29 |
| Published | 2021-09-08 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Teligent Pharma |
| Distribution | US |
Product
Lidocaine Ointment USP, 5% Rx Only, Net Wt 35.44 g(1 1/4 oz)packaged in a laminat tube, Teligent Pharma, Inc. Buena, New Jersey 08310, NDC 52565-008-14.
Reason
Failed Viscosity Specifications: lot does not meet specification for Viscosity, which was determined through routine testing.
Identifiers
| code_info | Lot #: 15378, Exp 3/2023; 14418 EXP 10/2021 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0785-2021%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.